Skip to main content
Advertisement
Advertisement
CNSY
CNSY logo
Cerenome, Inc. Common Stock
1.64
USD
Sponsored
-0.11
-6.29%
Oct 23, 15:59 UTC -4
Closed
exchange

After-Market

1.66

+0.02
+0.91%

Cerenome, Inc. Common Stock (CNSY) Earnings

CNSY Earnings Reports

Positive Surprise Ratio

CNSY beat 0 of 2 last estimates.

0%

Next Report

In 3 Days
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$938.74K
/
-$0.98
Implied change from Q2 26 (Revenue/ EPS)
+128.40%
/
-25.19%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-2.00%

Cerenome, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, CNSY reported earnings of -1.31 USD per share (EPS) for Q2 26, missing the estimate of -0.92 USD, resulting in a -41.13% surprise. Revenue reached 411.00 thousand, compared to an expected 1.13 million, with a -63.70% difference. The market reacted with a -13.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.98 USD, with revenue projected to reach 938.74 thousand USD, implying an decrease of -25.19% EPS, and increase of 128.40% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
argenx SE - ADR
Report Date
Oct 22, 2026 For Q3 26
Estimate
$8.19
Actual
$7.80
Surprise
-4.84%
logo
QIAGEN N.V.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.63
Actual
$0.65
Surprise
+2.43%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Oct 12, 2026 For Q3 26
Estimate
-$0.61
Actual
$4.73
Surprise
+871.74%
logo
Tiziana Life Sciences Ltd. Common Shares
Report Date
Oct 16, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.10
Surprise
-22.55%
FAQ
For Q2 2026, Cerenome, Inc. Common Stock reported EPS of -$1.31, missing estimates by -41.13%, and revenue of $411.00K, -63.7% below expectations.
The stock price moved down -13.04%, changed from $3.68 before the earnings release to $3.20 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on -- analysts, Cerenome, Inc. Common Stock is expected to report EPS of -$0.98 and revenue of $938.74K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement